University of Alabama - Division of Pulmonary and Critical Care Medicine — Birmingham, Alabama

University of Alabama - Division of Pulmonary and Critical Care Medicine is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of Alabama - Division of Pulmonary and Critical Care Medicine has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Interstitial Lung Disease Due to Systemic Disease, Scleroderma.

Sponsors: Scleroderma Research Foundation, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama - Division of Pulmonary and Critical Care Medicine?

University of Alabama - Division of Pulmonary and Critical Care Medicine has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama - Division of Pulmonary and Critical Care Medicine conducted?

University of Alabama - Division of Pulmonary and Critical Care Medicine has 1 clinical trials on record, with 1 currently active. Their work covers Interstitial Lung Disease Due to Systemic Disease, Scleroderma.

Is University of Alabama - Division of Pulmonary and Critical Care Medicine accredited by Crixeo Health?

University of Alabama - Division of Pulmonary and Critical Care Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama - Division of Pulmonary and Critical Care Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.